13F filing recap · Q2 2025
What did Dodge & Cox buy in Q2 2025?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every Dodge & Cox account, including accounts that belong to no fund below.
Stock value
$177.97B
Positions
219
Estimated turnover
13.6%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Dodge & Cox opened new positions in Teledyne Technologies, Amrize, Ralliant Corporation, Willis Towers Watson, Archer-Daniels-Midland, and Biontech, while exiting Becton Dickinson, iShares Trust, and Qurate Retail. The firm also added substantially to UnitedHealth Group, Regeneron Pharmaceuticals, GE Healthcare Technologies, Fortive, LPL Financial, Cemex, and Microchip Technology. Notable trims included General Electric, UBS Group, Bristol-Myers Squibb, Coherent, Gap, Williams Companies, and Cisco Systems.